| The trimer organisation of the Omicron spike protein ectodomain is similar to that of the original strain and all the earlier variants, according to cryo-EM structural study. The Omicron variant has 37 mutations in the spike protein, and 15 of which are in the receptor binding region (RBD) | The Omicron variant spike protein contains 3-5 times the number of mutations found in prior SARS-CoV-2 strains. Understanding the effects of these mutations on ACE2 receptor binding and neutralising antibody evasion is critical for developing effective therapies to stop the spread of the Omicron and related variations. ✍ | Pre-print (bioRXiv)
Title | SARS-CoV-2 Omicron Variant: ACE2 Binding, Cryo-EM Structure of Spike Protein-ACE2 Complex and Antibody Evasion | Impact factor | N/A | Date of Entry | 2022 Jan 10 |
|
| Cryo-EM structure of the Omicron variant spike protein in complex with human ACE2 reveals salt bridge between RBD N417 and ACE2 D30 is lost. R493, R498 form salt bridge with ACE2 residues E35, D38, respectively and S496 forms a hydrogen bond with ACE2 residue K353. | Compared to the Delta variant, new
interactions are formed as a result of the mutations Q493R, G496S and Q498R, and the salt bridge between RBD K417 and ACE2 D30 is lost.
✍ | Pre-print (bioRXiv)
Title | SARS-CoV-2 Omicron Variant: ACE2 Binding, Cryo-EM Structure of Spike Protein-ACE2 Complex and Antibody Evasion | Impact factor | N/A | Date of Entry | 2022 Jan 10 |
|
| Structural analysis was done to show the position of mutated residues in the Lambda spike regions (NTD and RBD). Three mutations (G75V, T76I, and RSYLTPGD246-253N) were presentin theN-terminal domain (NTD)and the deletion mutation (RSYLTPGD246-253N)mutation was observedin a loop structure(loop 5).Another protein region (Receptor binding domain) containstwo mutations (L452Q and F490S). In addition, the T859N mutation wasfound in a specificSpikesubunit (S2heptad repeat 1). | Loop 5 contains 246-260 residues, which was a loop structure designated in a previous study. ✍ | Pre-print (bioRXiv)
Title | SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance | Impact factor | N/A | Date of Entry | 2021 Dec 15 |
|